NYP/Morgan Stanley Children’s Hospital has one of the top programs in the nation for the diagnosis and treatment of pediatric vascular anomalies. The Vascular Anomalies Group evaluates patients with a variety of vascular tumors, malformations, and associated syndromes including the newly categorized PIK3CA-related overgrowth spectrum (PROS), formerly labeled overgrowth syndromes.
The Cleft & Craniofacial Center of Children's Hospital of NewYork-Presbyterian/ Morgan Stanley Children's Hospital has been approved through 2020 as a Cleft Palate Team and Craniofacial Team by the Commission on Approval of Teams according to the Standards for Cleft Palate and Craniofacial Teams. This designation indicates that the team meets the high standards of the American Cleft Palate-Craniofacial Association (ACPA) and Cleft Palate Foundation (CPF). Although the center has already been accredited since 1993, the new system of approval (as of 2014) entails a far more demanding set of requirements than before.